Journal of Neurogastroenterology and Motility 2019; 25(1): 175-175
Published online: January 1, 2019.
© The Korean Society of Neurogastroenterology and Motility. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

A Double-blind, Randomized, Multicenter Clinical Trial Investigating the Efficacy and Safety of Esomeprazole Single Therapy Versus Mosapride and Esomeprazole Combined Therapy in Patients With Esophageal Reflux Disease

Ju Yup Lee, Sung Kook Kim, Kwang Bum Cho, Kyung Sik Park, Joong Goo Kwon, Jin Tae Jung, Eun Young Kim, Byung Ik Jang, Si Hyung Lee, and Daegu-Gyeongbuk Gastrointestinal Study Group (DGSG)

(J Neurogastroenterol Motil 2017;23(2):218–228;

The original version of this article contains one mistake.

The term “protein pump inhibitors (PPIs)” in the Introduction of page 219 should have been written as “proton pump inhibitors (PPIs).”

This Article



Aims and Scope